ArticleActa pharmaceutica Sinica. B2025

Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through A

Jian Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.